BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7886013)

  • 21. Detection of the breakpoint cluster region-ABL fusion in chronic myeloid leukemia with variant Philadelphia chromosome translocations by in situ hybridization.
    Tosi S; Cabot G; Giudici G; Attuati V; Morandi P; Rambaldi A; Döhner H; Biondi A
    Cancer Genet Cytogenet; 1996 Jul; 89(2):153-6. PubMed ID: 8697423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia.
    Safley AM; Sebastian S; Collins TS; Tirado CA; Stenzel TT; Gong JZ; Goodman BK
    Genes Chromosomes Cancer; 2004 May; 40(1):44-50. PubMed ID: 15034867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The first report of a Philadelphia chromosome and BCR/ABL rearrangement positive myeloproliferative disorder in a child with thrombocythemia.
    Anguita E; Valverde F; González FA; Gil C; Mateo M; Ferro MT; Villegas A
    Leukemia; 1998 Mar; 12(3):442-4. PubMed ID: 9529142
    [No Abstract]   [Full Text] [Related]  

  • 24. Localisation and distance between ABL and BCR genes in interphase nuclei of bone marrow cells of control donors and patients with chronic myeloid leukaemia.
    Lukásová E; Kozubek S; Kozubek M; Kjeronská J; Rýznar L; Horáková J; Krahulcová E; Horneck G
    Hum Genet; 1997 Oct; 100(5-6):525-35. PubMed ID: 9341866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events.
    Gargallo P; Cacchione R; Chena C; Dupont J; Garay G; Riveros D; Larripa I; Slavutsky I
    Cancer Genet Cytogenet; 2005 Aug; 161(1):74-7. PubMed ID: 16080961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy.
    Dewald GW; Wyatt WA; Silver RT
    Leuk Lymphoma; 1999 Aug; 34(5-6):481-91. PubMed ID: 10492071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals.
    Mohr B; Bornhäuser M; Platzbecker U; Freiberg-Richter J; Naumann R; Prange-Krex G; Mohm J; Kroschinsky F; Ehninger G; Thiede C
    Cancer Genet Cytogenet; 2001 Jun; 127(2):111-7. PubMed ID: 11425449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD).
    Bartl R; Frisch B; Wilmanns W
    Eur J Haematol; 1993 Jan; 50(1):41-52. PubMed ID: 8436214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interpretation of submicroscopic deletions of the BCR or ABL gene should not depend on extra signal-FISH: problems in interpretation of submicroscopic deletion of the BCR or ABL gene with extra signal-FISH.
    Kim YR; Cho HI; Yoon SS; Park S; Kim BK; Lee YK; Chun H; Kim HC; Lee DS
    Genes Chromosomes Cancer; 2005 May; 43(1):37-44. PubMed ID: 15723338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11.
    Sessarego M; Fugazza G; Bruzzone R; Ballestrero A; Miglino M; Bacigalupo A
    Haematologica; 2000 Jan; 85(1):35-9. PubMed ID: 10629589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of a cell line with variant BCR/ABL breakpoint expressing P180BCR/ABL from late-appearing Philadelphia-positive acute biphenotypic leukemia.
    Inokuchi K; Shinohara T; Futaki M; Hanawa H; Tanosaki S; Yamaguchi H; Nomura T; Dan K
    Genes Chromosomes Cancer; 1998 Nov; 23(3):227-38. PubMed ID: 9790503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conventional and fluorescence in situ hybridization analysis of three-way complex BCR-ABL rearrangement in a chronic myeloid leukemia patient.
    Ganguly BB; Kadam NN; Agarwal MB
    J Cancer Res Ther; 2007; 3(2):124-6. PubMed ID: 17998739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bcr-abl translocation: diagnostic methods and clinical value].
    Pignon JM
    Ann Biol Clin (Paris); 1998; 56(1):57-63. PubMed ID: 9754223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescence in situ hybridization (FISH) is a reliable diagnostic tool for detection of the 9;22 translocation.
    Nolte M; Werner M; Ewig M; von Wasielewski R; Wilkens L; Link H; Ganser A; Georgii A
    Leuk Lymphoma; 1996 Jul; 22(3-4):287-94. PubMed ID: 8819078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [From conventional cytogenetics to microarrays. Fifty years of Philadelphia chromosome].
    Hernández JM; Granada I; Solé F;
    Med Clin (Barc); 2011 Jul; 137(5):221-9. PubMed ID: 20591449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCR/ABL fusion located on chromosome 9 in chronic myeloid leukemia with a masked Ph chromosome.
    Mohamed AN; Koppitch F; Varterasian M; Karanes C; Yao KL; Sarkar FH
    Genes Chromosomes Cancer; 1995 Jun; 13(2):133-7. PubMed ID: 7542908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of fluorescence in situ hybridization in defining a complex t(9;21;22) Ph formation.
    Mancini M; Nanni M; Cedrone M; De Cuia MR; Rondinelli MB; Malagnino F; Alimena G
    Haematologica; 1994; 79(6):536-9. PubMed ID: 7896212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescent in-situ hybridization (FISH) for BCR/ABL in chronic myeloid leukemia after bone marrow transplantation.
    Chauffaille Mde L; Oliveira JS; Romeo M; Kerbauy J
    Sao Paulo Med J; 2001 Jan; 119(1):16-8. PubMed ID: 11175620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
    Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
    Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia.
    Loncarevic IF; Römer J; Starke H; Heller A; Bleck C; Ziegler M; Fiedler W; Liehr T; Clement JH; Claussen U
    Genes Chromosomes Cancer; 2002 Jun; 34(2):193-200. PubMed ID: 11979553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.